Literature DB >> 15803861

Severe cholestatic hepatitis caused by azathioprine.

Christoph Eisenbach1, Christoph Goeggelmann, Christa Flechtenmacher, Wolfgang Stremmel, Jens Encke.   

Abstract

A male patient receiving azathioprine treatment for discoid lupus erythematodes developed severe cholestatic hepatitis between 14 and 21 days after initiation of the treatment with peak bilirubin levels of 62.4 mg/dL. Other causes of hepatic dysfunction including viral hepatitis were clinically and serologically excluded. Liver biopsy revealed cholestatic hepatocellular damage. At 14 days after discontinuation of azathioprine the liver function (transaminases and bilirubin) began to improve. Only alcaline phosphatase and gamma-glutamyl transferase remained elevated even after 4 months. This case argues for an idiosyncratic cholestatic hepatocellular damage caused by azathioprine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15803861     DOI: 10.1081/iph-51744

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  3 in total

1.  Azathioprine induced hepatitis in patients with inflammatory bowel disease.

Authors:  Rajaventhan Srirajaskanthan; Dilshad Valliani
Journal:  Int J Clin Pharm       Date:  2011-09-03

Review 2.  Azathioprine-induced hepatitis and cholestasis occurring 1 year after treatment.

Authors:  Jason Chertoff; Sabikha Alam; Michael Black; Islam Y Elgendy
Journal:  BMJ Case Rep       Date:  2014-12-03

Review 3.  Drug-induced liver injury: is it somehow foreseeable?

Authors:  Giovanni Tarantino; Matteo Nicola Dario Di Minno; Domenico Capone
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.